Searched for
JONATHAN HUNT SYNGENE
Syngene's MD & CEO Jonathan Hunt steps down, Peter Bains named as new CEOJonathan Hunt has stepped down as the managing director and CEO of Syngene International, with Peter Bains appointed as the CEO Designate e...- Syngene's capex on track; focus on R&D and biologics to fuel future expansion: Jonathan HuntWe predicted that during the course of this year, it would start to stabilise. We would see the beginnings recovery in that funding environ...
- Syngene poised to capitalize on China Plus One strategy, sees long-term opportunitiesSo, a return to growth in the second half on the revenue line and then operating leverage and improved margins in the second half of the ye...
- Syngene Q1 Results: Net profit drops 19% to Rs 76 croreSyngene International, the contract research and manufacturing services arm of Biocon, reported 19% year-on-year (YoY) drop in net profit t...
- Syngene Q4 Results: Net profit rises 6% to Rs 189 crore, revenue drops 8%The earnings before interest, tax, depreciation and ammortisation dropped 1% YoY to Rs. 333 crore in Q4FY24. The EBITDA margin rose 300 bas...
- Syngene International Q3 Results: Net profit rises 2% YoY to Rs 112 crore, company revises revenue guidanceThe rise in Q3 profit of Syngene International was led by dedicated centres and development and manufacturing services, even as discovery s...
- We expect mid-teen growth for full year despite softening of US biotech segment: Jonathan Hunt, SyngeneI think that restructuring and that evolution of becoming not only a bigger business, but one that is well balanced between both the manufa...
- Syngene International Q1 Results: Net profit jumps 26% to Rs 93 croreThe first quarter revenue from operations rose 26% YoY to Rs. 832 crore. The earnings before interest, tax, depreciation and ammortisation ...
- Syngene International sees strong momentum this fiscal year: MDSyngene International also expects business growth from its pharma clients who are keen to make up for the time that they felt they lost du...
- Syngene to benefit from rupee depreciation, rising demand for research & manufacturing services: CEO Jonathan HuntSyngene has raised the revenue guidance for FY23 from mid-teens to high teens due to significant depreciation of rupee against the dollar a...
- Seeing good demand for biologics manufacturing: Syngene CEO Jonathan HuntIn an interview to ET, Jonathan Hunt, CEO and MD of Syngene said the company has spare capacity and is also investing on expansion of micro...
- Syngene's CEO Jonathan Hunt says India now offers intellectual arbitrage to firms“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...
- Margin performance in line with expectations: Jonathan Hunt, Syngene"Given the second wave of the pandemic that we had in India, we have seen pretty strong sales on Remdesivir: the product that we manufactur...
- Syngene International Q3 results: Profit rises 11% to Rs 102 crRevenue from the operations stood at Rs 585 crore in the quarter under review. It was Rs 519 crore in December quarter 2019-20, it added.
- Syngene International Q4 results: Profit up 20% to Rs 120 croreThe company had posted a net profit of Rs 100 crore for the corresponding period of the previous fiscal.
- Syngene International Q2 profit up 64% at Rs 128 croreTotal income stood at Rs 485.2 crore for the quarter under review as against Rs 436.8 crore for the same period a year ago, it added.
- Syngene plans to scale up for biologicsSyngene, an arm of Biocon, is expanding its capital investment as it waits to complete a 40-acre, $100-million research facility in Mangalo...
- Syngene lines up $200 million capex to boost manufacturingSyngene offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology and toxicology.
- Syngene Q1 Net up 28% at Rs 60 croreThe company had posted a net profit of Rs 46.6 crore for the corresponding period of the previous fiscal, Syngene International said in a f...
- Syngene appoints Jonathan Hunt as CEO-designateHunt will take charge after the retirement of current CEO Peter Bains in March, Syngene International said in a regulatory filing.
Load More
